Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Post Micronesia.
Press releases published on April 16, 2025

Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis
Company-sponsored clinical trial will be initiated at FAU Erlangen-Nuremberg in Germany and Università Cattolica del Sacro Cuore, Rome in Q2 2025 CLN-978 is also being studied in the U.S., Europe, and Australia for systemic lupus erythematosus CAMBRIDGE, …

Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer
CONSHOHOCKEN, Pa., April 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that …

Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025
CHATHAM, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that …

Tilray Brands Ranks #4 on the Brewers Association List of Top Producing Craft Brewers in the United States
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Tilray Beverages, a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is pleased to announce that its U.S. Beverage division has achieved a significant milestone, ranking #4 on the Brewers …

INmune Bio Receives Favorable Patentability Opinion for CORDStrom™ Platform Technology
Boca Raton, Florida, US, April 16, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system, today announced a major intellectual property …

Skyvia Launches Public API Beta for Data Workflow Automation
PRAGUE, April 16, 2025 (GLOBE NEWSWIRE) -- Skyvia, the most comprehensive data integration platform, has announced the beta release of its highly anticipated Public API. The new feature responds directly to customer requests for enhanced flexibility, …

DIAGNOS announces major advances in Cybersecurity certification by the Cyber Defense Operations Center (COCD) for its CARA System application
BROSSARD, Quebec, April 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of certain ophthalmic health issues using advanced technology based on Artificial …

Orezone Reports Q1-2025 Production and Hard Rock Expansion Update
VANCOUVER, British Columbia, April 16, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased to announce its Q1-2025 gold production results and a construction update for the Stage I hard rock …

DIAGNOS annonce des avancées majeures dans sa certification de Cybersécurité par le Centre opérationnel de cyberdéfense (COCD) pour son application CARA System
BROSSARD, Québec, 16 avr. 2025 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), un pionnier de la détection précoce de certains problèmes de santé ophtalmique à l'aide d'une …

Kingsoft Cloud Announces Proposed Public Equity Offering and Concurrent Private Placement to Kingsoft Corporation
BEIJING, April 16, 2025 (GLOBE NEWSWIRE) -- Kingsoft Cloud Holdings Limited (“Kingsoft Cloud” or the “Company”) (NASDAQ: KC and HKEX: 3896), a leading cloud service provider in China, today announced the commencement of an underwritten public offering (the …

Aurora Mobile Launches Hong Kong Edition of JVerification to Streamline and Innovate Cross-Border Login and Verification
SHENZHEN, China, April 16, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services in China, today announced the official launch of the Hong …

RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME
RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME ISTURISA® is a cortisol synthesis inhibitor that blocks the enzyme 11β-hydroxylase to help normalize …

LearnWorlds hits 500,000 courses milestone, signaling demand for a new generation of elearning platforms
ATHENS, Greece, April 16, 2025 (GLOBE NEWSWIRE) -- LearnWorlds, the elearning platform that combines the power of an LMS with the agility of a modern course builder, has officially surpassed 500,000 courses created by its users. The milestone comes shortly …

Basilea berichtet über Präsentation neuer Daten zu Fosmanogepix, Isavuconazol (Cresemba®) und Ceftobiprol (Zevtera®) auf dem Fachkongress ESCMID Global 2025
Allschwil, 16. April 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren Infektionen durch Bakterien oder Pilze erkrankt sind, gab …

Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
Allschwil, Switzerland, April 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today scientific …

Santhera shares updates on commercial rollout of AGAMREE®
Pratteln, Switzerland, April 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD). Funding from National Health Service (NHS) England is …

HERE Technologies Showcases Software-Defined Vehicle Solutions for Chinese Automakers at Auto Shanghai 2025
HERE to showcase next-generation, AI-powered mapping and location solutions built for the connected, electric, automated and intelligent vehicle era Working alongside 30 leading Chinese automakers globally, HERE is the trusted provider for high-quality …

Santhera informiert über den kommerziellen Rollout von AGAMREE®
Pratteln, Schweiz, 16. April 2025 - Santhera Pharmaceuticals (SIX: SANN) gibt den neuesten Fortschritt beim kommerziellen Rollout von AGAMREE® zur Behandlung von Duchenne-Muskeldystrophie (DMD) bekannt. Für AGAMREE zur Behandlung von Duchenne- …

Ipsen delivers strong sales in the first quarter 2025 and confirms its full-year guidance
Total sales growth of 11.6% at CER1, or 11.7% as reported, driven by all three therapeutic areas and including an increasing contribution from Iqirvo and Bylvay. Tovorafenib regulatory submission to EMA2 for pediatric low-grade glioma. Confirmation of full …

Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l’exercice 2025
Croissance des ventes de 11,6% à taux de change constant1, ou 11,7% en données publiées, tirée par toutes les aires thérapeutiques, incluant une contribution croissante d'Iqirvo et de Bylvay. Soumission réglementaire à l'EMA2 de tovorafenib pour le gliome …